A detailed history of Xponance, Inc. transactions in Twist Bioscience Corp stock. As of the latest transaction made, Xponance, Inc. holds 4,702 shares of TWST stock, worth $227,576. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,702
Previous 5,377 12.55%
Holding current value
$227,576
Previous $264,000 19.7%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$36.72 - $58.88 $24,786 - $39,744
-675 Reduced 12.55%
4,702 $212,000
Q2 2024

Aug 14, 2024

BUY
$27.95 - $53.0 $150,287 - $284,981
5,377 New
5,377 $264,000
Q4 2021

Jan 31, 2022

SELL
$75.47 - $135.88 $167,543 - $301,653
-2,220 Closed
0 $0
Q3 2021

Nov 05, 2021

SELL
$95.64 - $131.48 $35,004 - $48,121
-366 Reduced 14.15%
2,220 $237,000
Q2 2021

Aug 12, 2021

BUY
$88.13 - $142.06 $227,904 - $367,367
2,586 New
2,586 $345,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.73B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.